Armata Pharmaceuticals, Inc. (ARMP) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Marina del Rey, CA, 美国. 现任CEO为 Deborah L. Birx.
ARMP 拥有 IPO日期为 1994-05-20, 60 名全职员工, 在 American Stock Excha, 市值为 $471.83M.
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
